REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Serum Bio-Technology Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Serum Bio-Technology Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Serum Bio-Technology Co., Ltd is a high-tech biopharmaceutical enterprise specializing in the research and development, production and operation of antitoxin and antiserum biological products. The company's main products include equine tetanus immunoglobulin (F(ab')2), antivenom series products, and anti-rabies serum. The company was established in 1999 and is headquartered in Shanghai City, China.

Headquarters
1288 Huaqing Road, Qingpu District, Shanghai
Shanghai; Shanghai; Postal Code: 201707

Contact Details: Purchase the Shanghai Serum Bio-Technology Co., Ltd. report to view the information.

Website: http://www.serum-china.com.cn

Basic Information
Total Employees:
Purchase the Shanghai Serum Bio-Technology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Serum Bio-Technology Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Serum Bio-Technology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Serum Bio-Technology Co., Ltd. report to view the information.
Incorporation Date:
November 09, 1999
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
34.05%
Purchase this report to view the information.
22.18%
Purchase this report to view the information.
2.77%
Purchase this report to view the information.
2%
Purchase this report to view the information.
1.93%
Subsidiaries
Shanghai Sailun Biotechnology Dafeng Co., Ltd.
100%
Shanghai Saiyuan Biotechnology Co., Ltd.
22%
Company Performance
Financial values in the chart are available after Shanghai Serum Bio-Technology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
4.31%▲
Total operating revenue
4.29%▲
Operating profit (EBIT)
26.16%▲
Net Profit (Loss) for the Period
23.92%▲
Total assets
1.45%▲
Total equity
2.1%▲
Operating Profit Margin (ROS)
7.43%▲
Net Profit Margin
5.74%▲
Return on Equity (ROE)
1%▲
Quick Ratio
-2.44%▼
Cash Ratio
3.61%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd.
 
Quantumpharm Inc.
Gansu Mogao Industrial Development Co.,Ltd
 
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Inventisbio Co., Limited (益方生物科技(上海)股份有限公司)
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo